The Major Genetic Determinants of HIV-1 Control Affect HLA Class I Peptide Presentation

By F. Pereyra, Xiaoming Jia, P. McLaren, A. Telenti, P. D. de Bakker, Bruce D. Walker, S. Ripke, C. Brumme, S. Pulit, M. Carrington and 327 more. Science, 2010

1,234 citations recorded by the source corpus.

Getting HIV Under Control Approximately 1 in 300 people infected with HIV are HIV “controllers” who are able to maintain long-term control of the virus without medication and who do not progress to AIDS. Uncovering the genetic basis for this ability is of great interest. Pereyra et al. (p. 1551, published online 4 November; see the Perspective by McMichael and Jones) now present genome-wide association results from patients enrolled in the International HIV Controllers Study. The analysis compared HIV controllers of European, African-American, and Hispanic descent with HIV progressors and found >300 variants that reached genome-wide significance, all of which were in the major histocompatibility class I (HLA) region on chromosome 6. Analysis of the effects of individual amino acids within classical HLA proteins revealed six independently significant residues, five of which lined the peptide-binding groove. Thus, differences in binding to viral peptide antigens by HLA may be the major factors underlying genetic differences between HIV controllers and progressors. MHC class I alleles are the major genetic determinants associated with people able to control HIV infection without therapy. Infectious and inflammatory diseases have repeatedly shown strong genetic associations within the major histocompatibility complex (MHC); however, the basis for these associations remains elusive. To define host genetic effects on the outcome of a chronic viral infection, we performed genome-wide association analysis in a multiethnic cohort of HIV-1 controllers and progressors, and we analyzed the effects of individual amino acids within the classical human leukocyte antigen (HLA) proteins. We identified >300 genome-wide significant single-nucleotide polymorphisms (SNPs) within the MHC and none elsewhere. Specific amino acids in the HLA-B peptide binding groove, as well as an independent HLA-C effect, explain the SNP associations and reconcile both protective and risk HLA alleles. These results implicate the nature of the HLA–viral peptide interaction as the major factor modulating durable control of HIV infection.

Subfields: Immunology, Virology

View Paper: https://www.semanticscholar.org/paper/6c93b957c3bdc1c2dc490d2da641924eeac79332

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

S. Rich
A. Sáez-Cirión
C. Bacchus
L. Hocqueloux
B. Han
V. Avettand-Fenoel
Suna Onengut-Gumuscu
I. Girault

Citations in the corpus

Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI Study (2013, background): “Protective HLA class I alleles (HLA-B*27 and B*57) have been consistently found to be overrepresented in cohorts of HICs [17,18,19] who spontaneously control HIV-1 infection.”
Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens (2013, background): “In addition, our group recently identified a key role for amino acid position 97 in HLA-B, which can account for almost all known classical allele associations with HIV control [17].”
Translating HIV sequences into quantitative fitness landscapes predicts viral vulnerabilities for rational immunogen design (2013, neutral): “Recent experiments with mousepox virus suggest that such long-peptide immunogens, if properly delivered, can redirect the host immune system to mount CTL responses capable of conferring protective immunity upon mice that are otherwise naturally susceptible to infection (Remakus et al., 2012).”